Our new pharmacovigilance e-book looks at PSUR’s, key performance indicators and more. Download the free e-book here.
In our 4th Acorn Regulatory Brexit whitepaper entitled ‘What’s Next’ we focus on the results of our extensive Brexit survey. We look at our survey respondents favoured locations for the EMA, the future of the MHRA and much more.
Our team of regulatory affairs experts are regarded as the thought leaders in the sector. They have worked on some of the most challenging and ground breaking regulatory projects in modern times. They regularly write for specialist periodicals and speak at industry events. In this, the first edition of ‘Regulatory Intelligence’ we have asked them […]
Now that the British Prime Minister has finally outlined her plans for the British departure from the European Union, we can better consider the implications that Brexit will have on the life sciences sector in our latest Brexit whitepaper. In this whitepaper ‘The Road Ahead’, our team of regulatory affairs experts look at issues such as the future […]
British Prime Minister Theresa May’s Lancaster House speech was much anticipated by many sectors, including the life sciences sector in the UK and further afield. In this brief PDF we look at the implications of her speech for the life sciences sector.